Transcriptomics

Dataset Information

0

SOX4 Drives a Cancer-Associated Fibroblast-like Transition in Adipose Stromal Cells to Promote Metabolic Disease


ABSTRACT: Adipose tissue dysfunction drives metabolic disease in obesity and is characterized by impaired adipogenesis, chronic inflammation, and fibrosis. Here, we define a pathogenic cancer-associated fibroblast-like (CAF-like) stromal population that accumulates in visceral adipose tissue during obesity under the control of the transcription factor SOX4. Obesity and TGFβ signaling induce SOX4 in mesenchymal stromal cells (MSCs), where it promotes a CAF-like transcriptional program while suppressing adipogenic differentiation. SOX4 activation in mouse MSCs exacerbated adipose inflammation, fibrosis, and glucose intolerance independently of adiposity. Conversely, Sox4 deletion reduced adipose immune cell accumulation and improved glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector of CAF-like cells. MDK inhibition in obese mice reduced adipose tissue inflammation and improved metabolic function, whereas MDK activation promoted inflammatory remodeling of adipose tissue. In human adipose tissue, SOX4 and MDK expression were elevated in type 2 diabetes, and SOX4 activated a CAF-like transcriptional program in human MSCs. Overall, these findings identify a TGFβ-SOX4-MDK axis that drives pathogenic stromal reprogramming in adipose tissue and contributes to metabolic disease.

ORGANISM(S): Mus musculus

PROVIDER: GSE333670 | GEO | 2026/05/28

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-05-03 | GSE216948 | GEO
2024-10-17 | PXD050811 | Pride
2022-04-19 | PXD024418 | Pride
2023-05-03 | GSE216950 | GEO
2021-04-01 | GSE167212 | GEO
2025-03-19 | GSE263446 | GEO
2025-03-19 | GSE263445 | GEO
2025-09-26 | PXD052894 | Pride
2021-09-10 | PXD024647 | Pride
2025-10-14 | GSE286364 | GEO